Related Experiment Video
Updated: Jul 14, 2026

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform
Published on: May 10, 2024
The -463G/A polymorphism in myeloperoxidase gene and cervical cancer
Alexander Mustea1, Georg Heinze, Jalid Sehouli
1Department of Gynaecology and Obstetrics, Charité, Campus Virchow-Klinikum, Medical University of Berlin, Augustenburger Platz 1, 13353 Berlin, Germany. alexander.mustea@charite.de
Background:
Cervical cancer is the leading cause of cancer-related death in women in developing countries. The -463 type G polymorphism of the MPO gene has been correlated with higher MPO expression and increased risk of various types of cancers. Our study was performed in order to evaluate the association between the -463G polymorphism and the prevalence of cervical cancer.
Materials And Methods:
In our prospective study, 149 patients with cervical cancer and 126 patients without any malignancies were enrolled.
Results:
No significant difference was found between genotype distributions in the cervical cancer patients and the control group. There was also no significant association of the genotype distributions with clinical prognostic factors. However, significantly lower A allele frequency of the -463 polymorphism of the MPO gene was found in our study group in comparison with that of the average Caucasian population.
Conclusion:
The -463 polymorphism of the MPO gene was not associated with susceptibility to cervical cancer.
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Abnormal Proliferation
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
Single Nucleotide Polymorphisms-SNPs